However, based on the attributable risk, 24 patients would need to be treated for 3 years to prevent a single (incident) gout flare leading to the recommendation against initiating ULT in this patient group. Initiating ULT is conditionally recommended against in patients with asymptomatic hyperuricemia. For patients with asymptomatic hyperuricemia, RCTs (designed to study CVD outcomes) demonstrated significant reduction in incident gout flares over 3 years. However, the development of incident